Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Molecular genetics of meningiomas: Building the roadmap towards personalized therapy.
[proteus syndrome]
New
advances
have
recently
been
made
in
the
field
of
molecular
genetics
and
mouse
modeling
of
meningiomas
,
opening
new
perspectives
for
future
treatments
.
Recent
genome-
wide
genotyping
and
exome
sequencing
studies
have
confirmed
the
pivotal
role
of
NF
2
in
meningioma
tumorigenesis
,
concerning
roughly
half
of
the
tumors
,
and
unraveled
new
mutations
in
non-
NF
2
meningiomas
concerning
AKT
1
,
SMO
,
KLF
4
and
TRAF
7
.
The
molecular
mechanisms
underlying
tumorigenesis
of
high
histological
grades
have
been
progressively
deciphered
with
the
recent
discovery
of
TERT
promoter
mutations
in
progressing
tumors
.
A
better
understanding
of
the
genetics
and
clinical
behavior
of
high
-grade
meningiomas
is
mandatory
in
order
to
better
design
future
clinical
trials
.
New
genetically
engineered
mouse
models
of
benign
and
histologically
aggressive
meningioma
represent
a
substantial
resource
for
the
establishment
of
relevant
pre-clinical
trials
.
By
studying
the
mechanisms
underlying
these
new
tumorigenesis
pathways
and
the
corresponding
mouse
models
,
we
should
be
able
to
offer
personalized
chemotherapy
to
patients
with
surgery-
and
radiation-refractory
meningiomas
in
the
near
future
.
Diseases
Validation
Diseases presenting
"future clinical trials"
symptom
alexander disease
epidermolysis bullosa simplex
erythropoietic protoporphyria
junctional epidermolysis bullosa
krabbe disease
proteus syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom
